The Office of National Drug Control Policy was created by the Anti-Drug Abuse Act of 1988 which authorized ONDCP to set drug policy priorities, implement a comprehensive and research-based national strategy, and certify Federal drug policy budgets.

The Violent Crime Control and Law Enforcement Act of 1994 expanded ONDCP’s mission to include assessing budgets and resources related to the National Drug Control Strategy.

Executive Orders 12880 (1993), 12992 (1996), and 13023 (1996) tasked ONDCP with the responsibility to lead the United States’ drug policy and reiterated that ONDCP’s Director is the Executive Branch’s senior drug policy official.

The Drug Free Communities Act of 1997 authorized ONDCP to carry out a national initiative that awards Federal grants directly to community coalitions.

The Media Campaign Act of 1998 directed ONDCP to conduct a national media campaign for the purpose of reducing and preventing drug use among young people in the United States.

The Office of National Drug Control Policy Reauthorization Act of 1998 expanded ONDCP’s mandate and authority, including:

• Development of a long-term national strategy
• Implementation of a robust performance-measurement system
• Commitment to a five-year national program budget
• Permanent authority for the High Intensity Drug Trafficking Areas grant program
• Increased reporting to Congress on drug policy activities
• Reorganization of ONDCP to allow more effective national leadership
• Improved coordination among national drug program agencies

Executive Order 13165 (2000) created the White House Task Force on Drug Use in Sports. It authorized the Director of ONDCP to serve as the U.S. Government’s representative on the board of the World Anti-Doping Agency.

The ONDCP Reauthorization Act of 2006 reauthorized ONDCP through FY 2010 and expanded the mandate of the Agency, including:

• Statutorily creating the position of the U.S. Interdiction Coordinator (USIC) and the Interdiction Committee (TIC) within ONDCP
• Adding faith-based organizations and tribal officials to the National Drug Control Strategy consultation list
• Establishing a HIDTA designation petition process

The SUPPORT for Patients and Communities Act of 2018 reauthorized ONDCP through FY 2023, expanded ONDCP’s mandate, and made other changes, including:

Creating a cadre of coordinators at ONDCP to lead efforts on key drug issues

Reauthorizing the High Intensity Drug Trafficking Areas and the Drug Free Communities grant programs at ONDCP

Creating an Emerging Threats Committee tasked with proactively identifying and preparing for the next drug crises

Allowing a portion of HIDTA funds to be used for prevention and treatment

Creating an online Drug Control Data Dashboard with search functions

Creating a Grant Tracking System to better track and improve federal drug grants

The Drug-Free Communities (DFC) Support Program, created by the Drug-Free Communities Act of 1997, is the Nation’s leading effort to mobilize communities to prevent youth substance use.  Directed by ONDCP in partnership with CDC, the DFC program provides grants to over 500 community coalitions to strengthen the infrastructure among local partners to create and sustain a reduction in local youth substance use.

DFC coalitions bring together representatives from 12 community sectors to build strong local partnerships focused on preventing youth substance use. By engaging youth, parents, schools, business, media, law enforcement, faith-based/fraternal organizations, healthcare professionals, civic/volunteer groups, state, local and/or tribal governments, youth-serving organizations, and other key stakeholders, coalitions create data-driven action plans tailored to local needs. The majority of DFC-funded coalitions focus on preventing youth use of alcohol, tobacco, marijuana, prescription drug, opioids, including fentanyl and fentanyl analogs, methamphetamine, and xylazine use.

An estimated 62 million people (18 percent of the U.S. population) lived in communities served by DFC-funded coalitions in 2025.  This included approximately 2.4 million middle school youth ages 12 to 14 (18 percent of all middle school youth) and about 3.2 million high school youth ages 15 to 18 (18 percent of all high school youth).  Across DFC-funded coalitions in 2025, approximately 42,600 community members were mobilized to engage in prevention efforts, including approximately 10,800 youth.

Coalitions conduct regular needs assessments and use local data to identify priorities, guide planning, and measure progress. Central to this work is understanding the risk factors that increase the likelihood of youth substance use, as well as the protective factors that help young people thrive and make healthy choices. Using this information, coalitions implement comprehensive, evidence-based strategies designed to strengthen protective environments, reduce risk, and prevent youth substance use across the community.

Grant Recipients

Through the High Intensity Drug Trafficking Areas (HIDTA) Program, ONDCP supports collaborative Federal, state, local, tribal, and territorial law enforcement and public health efforts to disrupt drug trafficking and production and save American lives. HIDTA integrates with Homeland Security Task Forces (HSTFs) to continue the homeland offensive against foreign terrorist organizations (FTOs) and transnational criminal organizations (TCOs) attempting to smuggle drugs into American communities. The United States has adopted a whole-of-government approach to degrade and dismantle these FTOs and TCOs, recognizing that every available tool must be leveraged to eliminate these cartels as a national security threat to the United States.

The signing of Executive Order (EO) 14367 Designating Fentanyl as a Weapon of Mass Destruction (WMD) empowered HSTFs to identify, target, and dismantle cartels and foreign networks involved in the distribution and supply of illicit fentanyl and other illicit drugs. HIDTA is working tirelessly alongside HSTFs to cripple TCO logistics, maximize criminal prosecutions, root out money laundering operations that provide support to these networks, dismantle online drug trafficking networks, and disrupt the flow of firearms.

About

Created by Congress in 1988, the High Intensity Drug Trafficking Areas (HIDTA) Program coordinates and assists Federal, state, local, tribal, and territorial law enforcement agencies to address regional drug threats with the purpose of reducing drug trafficking, drug production, and drug use in the United States.

The National HIDTA Program encompasses 33 regional HIDTAs in all 50 states, Puerto Rico, the U.S. Virgin Islands, and the District of Columbia. Nationwide, the HIDTA Program comprises 1,032 initiatives distributed among the following categories: Enforcement, Intelligence, Prosecution, Management, Prevention, Treatment, and Support. Of those, over 100 were designated as Homeland Security Task Forces between 2025-2026. Regional HIDTAs also collaborate closely with public health partners on innovative strategies to reduce fatal and non-fatal overdoses and substance use.

Each HIDTA is guided by an Executive Board that includes an equal number of regional Federal and non-federal (state, local, tribal, and territorial) law enforcement leaders and is managed by an Executive Director. Law enforcement officials interested in participating in the HIDTA Program can view the Designation Process below for more information.

For more information about the HIDTAs’ work and successes, see the Program Impacts below.

To view the most current HIDTA Designation Map, click here.

Program Impacts

Since its inception in 1988, the HIDTA Program has helped public safety officials implement integrated operations against drug trafficking organizations and, with ONDCP’s leadership, has provided the American people with a cost-effective solution to address addiction and the overdose crisis. In 2025, the HIDTAs seized an estimated $22 billion in illicit drugs and cash—representing a return on investment of $82.78 for every $1 budgeted for the HIDTA Program.

• Removing drugs from our streets. By interdicting and seizing drugs off our shores and within our borders, HIDTAs remove the supply of illicit substances, making it harder for drug trafficking organizations (DTOs) to sell their products. In 2025, the HIDTA Program seized and disposed of over 211 metric tons of cocaine, 137 metric tons of methamphetamine, 1,508 metric tons of marijuana, 1.6 metric tons of heroin, and 7 metric tons of fentanyl.
• Dismantling drug trafficking organizations. By targeting DTOs, the HIDTAs focus on the entities responsible for the majority of the production, movement, and sales of illicit drugs. In 2025, the HIDTAs disrupted and dismantled over 3,383 DTOs, 51 percent of which were part of international or multi-state operations.
• Promoting best practices and innovations. As a result of the HIDTA Program’s national footprint, public safety officials across the country can share their best practices and information with each other and the HIDTAs can share on-the-ground intelligence with Federal agencies for better drug policy.
• Promoting non-drug use as the social norm. By establishing alliances with public health, healthcare, education, recreation, and other relevant sectors, the HIDTAs help create comprehensive community-based prevention efforts. 
• Enhancing officers’ safety and coordination. In 2025, the HIDTAs helped public safety agencies share more than 1 million pieces of evidence to unearth connections between cases and perform more than 335,000 event deconflictions, actions that can alert law enforcement officials when their tactical operations are occurring in the same general location and timeframe as other agencies. This has reduced unnecessary officer injuries and contributed to more equitable and appropriate arrests and convictions.

A comprehensive report on HIDTA program accomplishments is available here[DMLE1] .

Designation Process

ONDCP accepts petitions for county-based HIDTA designation on an ongoing basis and reviews these applications at least once a year. Regional law enforcement agencies may petition ONDCP for designation as a HIDTA, but new applicants typically request to be admitted to the closest-established HIDTA. Applicants can click here to select a region and find the Executive Directors’ contact information.

Criteria for Applying

Congress has established the following criteria for determining if a county should receive HIDTA designation:

1. The area is a significant center for illegal drug production, manufacturing, importation, or distribution;
2. State, local, tribal, and territorial law enforcement agencies have committed resources to address the drug trafficking problem in the area, thereby indicating a determination to respond aggressively to the problem;
3. Drug-related activities in the area are having a harmful impact in the area and in other areas of the country; and
4. A significant increase in allocation of federal resources is necessary to respond adequately to drug-related activities in the area.

Petitioning ONDCP for HIDTA status

The HIDTA Program does not have a pre-set application. Applicants can submit their petition to ONDCP for HIDTA designation by presenting relevant information in sections corresponding to the four criteria listed above. More information about the requirements of the petition process can be found in the Federal Register.

Applicants should direct any questions and completed petitions to the ONDCP National HIDTA Program.

 [DMLE1]

Combating Overdose through Community-Level Intervention (COCLI) is a collaborative effort between ONDCP and the Centers for Disease Control and Prevention (CDC) to implement and evaluate community-based efforts to fight the overdose epidemic. These efforts support innovative approaches to help the regions and populations within the United States that suffer from the highest rates of fatal and non-fatal drug overdoses.

The recipient of the 2022 COCLI cooperative agreement is the University of Baltimore’s Center for Drug Policy and Prevention, which provides opportunities for communities to receive COCLI funding through competitive subawards. Additional information is available here.

To view the current cooperative agreement terms and conditions, please click here.

To view previous cooperative agreement terms and conditions, please click here.

The White House Office of National Drug Control Policy, in partnership with the Legislative Analysis and Public Policy Association (LAPPA), has developed several Model State Drug Laws to serve as a resource for states in the development effective substance use disorder policies. These model laws include:

• Model Law Enforcement and Other First Responders Deflection Act: Encourages the use and establishment of deflection programs on the state level. Deflection programs provide proactive policing to assist individuals who are at risk and offer pathways to treatment, recovery services, housing, medication for addiction treatment, whole family services, and other needed supports.
• Model Expanded Access to Emergency Opioid Antagonists Act: Provides state officials with the means to increase the ability of their citizens to access and use life-saving emergency opioid antagonists. Opioid antagonists, such as naloxone, which can be used during emergencies to reverse opioid overdoses and are effective in preventing fatal drug overdoses.
• Model Opioid Litigation Proceeds Act: Assists states in their efforts to maximize funds available to address the overdose crisis through the establishment of a dedicated fund, separate from the state’s general treasury fund, that is designated for substance use disorder abatement, including prevention, treatment, recovery, and harm reduction infrastructure, programs, services, supports, and resources. All proceeds received by the state arising out of legal claims made against manufacturers and distributors of prescription opioid analgesics, pharmacies that dispensed prescription opioid analgesics, and related parties shall be deposited into the dedicated fund.
• Model Overdose Fatality Review Teams Act: Assists states in setting up county-level, multidisciplinary teams to identify challenges unique to a local area. It addresses the duties, responsibilities, and composition of Overdose Fatality Review (OFR) teams in order for them to properly examine and understand the circumstances leading up to a fatal overdose.
• Model Overdose Mapping and Response Act: Assists states in  addressing overdose incident reporting. The Model Act requires a state (or other jurisdiction) to create an overdose mapping and response system using ODMAP where all law enforcement officers, other first responders, medical examiners, and coroners must report certain information about a confirmed or suspected overdose incident within 24 hours. 

Additionally, LAPPA has released reports on timely drug policy topics:

• Performance Measures for Medication-assisted Treatment in Correctional Settings: A Framework for Implementation: This report provides professionals at correctional settings with a performance management framework to monitor medication treatment for opioid use disorder in correctional settings and recommends twelve performance measures to track key activities associated with corrections-based medication treatment programs and their impacts.
• Telehealth and Substance Use Disorder Services in the Era of COVID-19: Review and Recommendations: This report found that telehealth services can provide increased access to vulnerable individuals with substance use disorder, decrease costs, and reduce spread of communicable diseases.

Model law descriptions retrieved from the Legislative Analysis and Public Policy Association.

State officials interested in implementing model laws can contact ONDCP with any questions or requests for additional information.

In 2018, as part of the ONDCP reauthorization, which was embedded in the larger Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act of 2018 (P.L. 115-271) Congress created a requirement (21 U.S.C. §1704 (f)) for ONDCP to establish a tracking and reporting system for federally funded drug-related grant programs. The purpose of the new laws is to:

• Ensure the public has electronic access to information identifying: all drug control grants and pertinent identifying information for each grant; any available performance metrics, evaluations, or other information indicating the effectiveness of such programs.
• Facilitate efforts to identify duplication, overlap, or gaps in funding to provide increased accountability of Federally funded grants for substance use disorder treatment, prevention, and enforcement.
• Identify barriers in the grant application process impediments that applicants currently have in the grant application process with applicable agencies.

In response to this requirement ONDCP established a process to collect drug-related grant information from all national drug control program agencies with drug control grant programs. This information is consolidated into web links at Grants.Gov and USASpending.Gov. Although there is some overlap between the systems, generally the Grants.Gov link is the best source for currently available funding opportunities while USASpending.Gov has a deeper history of past grant programs. The specific links are below.

Links:

Grants.Gov: Search Grants | GRANTS.GOV

USASpending.Gov: Federal Awards | Advanced Search | USAspending

Note that once on the specific website, the information can be tailored in a number of ways, including by agency, by keyword, and by fiscal year. For example, information on grants.gov include links by “opportunity number.” Clicking on that number brings you to a dedicated description of the program and more information about the program, how to apply, and additional information and web links. Agencies provide available performance and outcome data within their program documents under each grant program.

Contacts:

As referenced above, specific information about agency grants are embedded within each specific agency grant. Agencies awarding the grants are the best source for specific information about their programs. For information about ONDCP grant programs or about the grant tracking process, please contact us at: performancebudgetcoordinator@ondcp.eop.gov

ONDCP’s Grant Programs:

The Drug-Free Communities (DFC) Support Program is the Nation’s leading effort to mobilize communities to prevent youth substance use. DFC performance information can be found here.

The High Intensity Drug Trafficking Areas (HIDTA) Program, since its inception in 1988, has helped public safety officials implement integrated operations against drug trafficking organizations. HIDTA Program performance information can be found here.

Wastewater Newsletters

The ONDCP Drug Control Data Dashboard was mandated by Congress (21 U.S.C. § 1705 (f)) and provides a machine-readable and interactive collection of drug data from many sources. compiles these data from primary data sources and works with the data source agencies and organizations to regularly update the Dashboard. The Dashboard provides users the ability to search topics by year, agency, drug, and, to a limited degree, geographic location.

Please note: Although data are available for many specific drug topics, some are incomplete or dated and in need of new or updated data and research. 

For an overview of the drug data dashboards and their respective Substance Use Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities (SUPPORT) Act requirements, please visit the Drug Control Data Dashboard.

Access the individual Drug Control Data Dashboards here:

Fatal and Non-fatal Overdoses

Opioid-Related Hospital Visits

Drug Induced Deaths

Drug Overdose Deaths

Unintentional Drug Overdose Deaths

Drug Overdose and Other Injury Deaths

Supply Reduction

Drug Seizures Submitted to Forensic Labs

Illicit Marijuana Eradication

Drug Production, Cultivation, and Eradication

Drug Price and Purity

Arrests by Type of Offense and Drug

Substance Use

Estimated Drug Consumption

Dispensed Opioid Prescriptions

Frequency of Substance Use

Economic Costs of Drug Abuse

Drug Use by Employment Status

Positive Drug Tests in the Workforce

Positive Drug Tests Among Male Arrestees

Illicit Drug Use Disorder

Initiation of Substance Use

Substance Use Disorder Treatment

Medicaid Beneficiaries Treated for a SUD

Admissions to Substance Use Treatment Facilities

Individuals in Need of SUD Treatment

FY 2026 Good Accounting Obligation in Government Act Report Executive Summary

FY 2026 Good Accounting Obligation in Government Act Report

Quarterly FOIA Reports

ONDCP 2024 Q4 Quarterly FOIA Report

ONDCP 2025 Q1 Quarterly FOIA Report

ONDCP 2025 Q2 Quarterly FOIA Report

ONDCP 2025 Q3 Quarterly FOIA Report

ONDCP 2025 Q4 Quarterly FOIA Report

Annual FOIA Reports

FY 2025 Annual Report

Chief FOIA Officer Reports

Frequently Requested Records

Ethics

The ONDCP Office of General Counsel (OGC) serves as the designated agency ethics office. OGC provides legal advice and counsel on a full range of ethics matters including avoiding conflicts of interest, gift rules and filing public and confidential financial disclosure reports among others. If you would like to request public financial disclosure reports filed by ONDCP staff, please submit OGE Form 201 to foia@ondcp.eop.gov.  OGC will process requests for public financial disclosure reports in accordance with 5 U.S.C. App. § 105.